Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT01950572 2026-03-13

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Recruiting

1,000 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Biliary Tract Neoplasms, Lung Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thymoma

NCT04266093 2026-03-13

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Enrolling by invitation

1,000 enrolled

GynecologicHead & Neck

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Squamous Intraepithelial Lesions of the Cervix

Clinical Trials

National Cancer Institute "Cancer Moonshot Biobank"

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance

A Follow-up Study of Women Evaluated and Treated for Infertility

Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

Blood Collection From People With Ovarian Cancer

Assessment of Screening Modalities for Gynecologic Cancers

Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples

Continuation of Follow-up of DES-Exposed Cohorts

Improving Cervical Cancer Screening Among HIV-Infected Women in India

Extended Follow-up of Columbia, MO Serum Bank Participants

Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer

Molecular Staging of Endometrial Cancer

Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer

Cervix Image Sharing Protocol (CISP)

Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics

Bone Mineral Density and Subsequent Cancer Risk

Cervical Cancer Early Endpoints and Determinants

A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)

Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans

Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta

Microarray Analysis for Human Genetic Disease

PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2

A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening

Low-Cost Molecular Cervical Cancer Screening Study

Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gastrointestinal Cancer or Gynecological Cancer

Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom

Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01

Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer

Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171

Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer

Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182

Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer

Environmental Factors in the Development of Polycystic Ovary Syndrome

Outcomes of Education and Counseling for BRCA1 Testing